drugset / Trial / NCT04367428
Pre- and Postoperative Probiotics Administration in Patients Undergoing Sleeve Gastrectomy
RandomizedParallel-groupOpen-labelTreatment
Summary
Patients will be randomized into 2 groups: * G1: Patients undergoing sleeve gastrectomy as bariatric procedure and receiving pre- and postoperative probiotics * G2: Patients undergoing sleeve gastrectomy as bariatric procedure and not receiving pre- or postoperative probiotics Weight loss will be assessed 1 year after surgery
Timeline
- Start
- 2020-05-02
- Primary completion
- 2021-07-31
- Completion
- 2021-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bifidobacterium bifidum BB 06 | Unknown | — | — |
| Subject | Bifidobacterium breve BB 03 | Unknown | — | — |
| Subject | Bifidobacterium lactis BL 04 | Unknown | — | — |
| Subject | Bifidobacterium longum BL 05 | Unknown | — | — |
| Subject | bifidobacterium bifidum BGN 4 | Unknown | — | — |
| Subject | enterococcus faecium UBEF-41 | Unknown | — | — |
| Subject | lactobacillus acidophilus LA 14 | Unknown | — | — |
| Subject | lactobacillus rhamnosus HN001 | Unknown | — | — |
| Subject | lactobacillus rhamnosus LR 32 | Unknown | — | — |
| Subject | lactobacillus salivarius LS 33 | Unknown | — | — |
| Subject | saccharomyces boulardii ntc 5375 | Unknown | — | — |
Indications
No indication recorded.